<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Hepatol</journal-id>
      <journal-id journal-id-type="publisher-id">KJHEP</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Hepatology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-222X</issn>
      <issn pub-type="epub">2093-8047</issn>
      <publisher>
        <publisher-name>The Korean Association for the Study of the Liver</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21494082</article-id>
      <article-id pub-id-type="pmc">3304628</article-id>
      <article-id pub-id-type="doi">10.3350/kjhep.2011.17.1.76</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Liver Pathology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>IgG4-related sclerosing cholangitis: liver biopsy findings</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ryu</surname>
            <given-names>Han Suk</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Haeryoung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Haeryoung Kim. Department of Pathology, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam 463-707, Korea. Tel. +82-31-787-7715, Fax. +82-31-787-4012, <email>medannabel@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>1</issue>
      <fpage>76</fpage>
      <lpage>79</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 by The Korean Association for the Study of the Liver</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>IgG4</kwd>
        <kwd>Sclerosing cholangitis</kwd>
        <kwd>Liver</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>IgG4-related autoimmune disease is a recently recognized clinical entity associated with autoimmune pancreatitis, various systemic extrapancreatic lesions and an elevated serum IgG4 level.<xref ref-type="bibr" rid="B1">1</xref> IgG4-related sclerosing cholangitis (IgG4-SC) is one of the extrapancreatic manifestations of this entity, which needs to be differentiated from primary sclerosing cholangitis (PSC) as these two diseases appear similar at presentation, but follow different clinical courses. In this issue, we will discuss the histopathologic findings of IgG4-SC based on a liver biopsy case of a 65-year-old patient with autoimmune pancreatitis.</p>
    </sec>
    <sec>
      <title>CASE SUMMARY</title>
      <p>A 65-year-old previously healthy male presented with sharp epigastric pain and fever for the past two days. He had received a pylorus-preserving pancreaticoduodenectomy under the impression of a distal common bile duct cancer 3 years ago. He had a smoking history of 40-packs per year and a recent history of alcohol ingestion before surgery. Initial aspartate aminotransferase and alanine aminotransferase levels were 147 IU/L and 150 IU/L, respectively. The initial laboratory data showed an increased white blood cell count (13,300/&#xB5;L) and C-reactive protein level (5.3 mg/dL). Serologic markers for hepatitis B surface antigen (HBsAg), IgM anti-HBc, IgM anti-hepatitis A virus antibody, and anti-hepatitis C virus antibody were all negative. Tumor markers and antinuclear antibody were also negative. Abdominal computed tomography and ultrasonography demonstrated a soft tissue infiltration around the common hepatic duct with bile duct dilatation and an ill-defined thickening of the bile duct wall at the hilar portion, suggestive of IgG4-SC. Serum IgG4 level was increased up to 196 mg/dL, and the serum IgG4/IgG ratio was 16.6%. A needle biopsy of the liver was performed.</p>
    </sec>
    <sec>
      <title>PATHOLOGIC FINDINGS</title>
      <p>Microscopic evaluation of liver biopsy revealed moderate inflammatory cell infiltrates in a few portal tracts (<xref ref-type="fig" rid="F1">Fig. 1A, 1B</xref>). The inflammatory cells comprised lymphocytes, plasma cells and eosinophils. The infiltration was mainly centered around the portal veins with endothelial damage. The hepatic arteries and bile ducts were spared by the inflammatory infiltrates and degeneration of bile duct epithelial cells was not identified. Mild ductular reaction was seen in at the portal-parenchymal interface. The portal fibrosis was mild, and there was no evidence of an 'onion-skin' pattern. The lobular inflammatory infiltrate was mild. Immunohistochemical stain revealed a few portal tracts containing up to 12 IgG4-positive plasma cells per high-power microscopic field (<xref ref-type="fig" rid="F1">Fig. 1C</xref>).</p>
      <p>The previously resected pancreas demonstrated a dense lymphoplasmacytic infiltrate affecting the parenchyma with septal fibrous bands (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). The ductal epithelium was relatively intact despite the periductal dense inflammatory cell infiltrate (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Obliterative phlebitis was frequently noted in the pancreatic parenchyma (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). Immunohistochemistry demonstrated abundant IgG4-positive plasma cells with an average of 43 IgG4-positive plasma cells per high power field (<xref ref-type="fig" rid="F2">Fig. 2D</xref>).</p>
    </sec>
    <sec>
      <title>DISCUSSION</title>
      <p>The discrimination between IgG4-SC and pancreaticobiliary malignancies and PSC is an important issue. IgG4-SC responds well to steroid therapy or biliary drainage, while PSC is progressive and resistant to steroid therapy, resulting in the involvement of both the intra-and extrahepatic ducts and culminating in biliary cirrhosis.<xref ref-type="bibr" rid="B2">2</xref> Clinically, PSC usually occurs in younger patients and presents with obstructive jaundice more commonly than IgG4-SC. PSC is commonly associated with inflammatory bowel disease, whereas IgG4-SC is associated with autoimmune pancreatitis.<xref ref-type="bibr" rid="B3">3</xref> The measurement of serum IgG4 levels is useful for differentiating between these two disorders; according to previous studies, increased serum IgG4 levels exceeding 135 mg/dL are frequently seen in these patients.<xref ref-type="bibr" rid="B4">4</xref></p>
      <p>Hepatic involvement of IgG4-SC can manifest as an overt mass-like lesion or as a mild to moderate portal lymphoplasmacytic infiltration.<xref ref-type="bibr" rid="B5">5</xref> Tumefactive lesions characterized by diffuse lymphoplasmacytic infiltration and prominent eosinophilic infiltration have been classified as the "lymphoplasmacytic type" of inflammatory pseudotumors by Zen et al,<xref ref-type="bibr" rid="B6">6</xref> and these lesions have been proposed to belong to the spectrum of IgG4-related diseases. In addition to the lymphoplasmacytic and eosinophilic inflammatory infiltrates, obliterative phlebitis and cholangitis with periductal fibrosis have been found to be common features.</p>
      <p>The liver pathology of IgG4-SC is different from that of PSC in the following aspects. IgG4-SC usually leaves the epithelial cells of the bile ducts intact, despite the remarkable periluminal inflammatory cell infiltration, while PSC is characterized by degenerative bile duct lesions and ductopenia.<xref ref-type="bibr" rid="B7">7</xref> The portal inflammatory infiltrate of IgG4-SC consists of a dominant proportion of lymphocytes and plasma cells and also numerous eosinophils, whereas PSC shows a lesser degree of portal inflammation and neutrophilic infiltration.<xref ref-type="bibr" rid="B5">5</xref> The periductal "onion-skin" fibrosis formed by well-organized lamellated collagen bands seen in PSC is absent in IgG4-SC,<xref ref-type="bibr" rid="B3">3</xref> and obliterative phlebitis is more commonly identified in IgG4-SC.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B8">8</xref> Lobular inflammation composed of lymphocytes and scattered plasma cells and eosinophils is a common finding in IgG4-SC, while it is significantly less frequently seen in PSC.<xref ref-type="bibr" rid="B7">7</xref> Finally, it is important to demonstrate by immunohistochemistry the increased number of IgG4-positive plasma cells in the tissue in order to differentiate between the two diseases.</p>
      <p>There is currently no established scoring criteria for IgG4 immunostaining in the biliary tract; however, most reports have demonstrated that the number of IgG4-positive plasma cells in extrahepatic bile ducts affected by IgG4-SC usually exceeds 30 per high-power field.<xref ref-type="bibr" rid="B5">5</xref> As for the peripheral bile ducts of small portal tracts, marked heterogeneity in the degree of IgG4-positive plasma cell infiltration has been noted: for example, several portal tracts may lack the IgG4-positive cells entirely.<xref ref-type="bibr" rid="B7">7</xref> Nevertheless, although there are discrepancies regarding the amount of IgG4-positive plasma cell infiltrates seen in small portal tracts obtained by needle biopsies, immunohistochemistry for IgG4 is an important part of the diagnosis of IgG4-SC, as IgG4-positive plasma cells are absent or rare in PSC.<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref></p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kamisawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Funata</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Eishi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tsuruta</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new clinicopathological entity of IgG4-related autoimmune disease</article-title>
          <source>J Gastroenterol</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>982</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">14614606</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakazawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis</article-title>
          <source>Pancreas</source>
          <year>2005</year>
          <volume>30</volume>
          <fpage>20</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">15632695</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakazawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ando</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naitoh</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Joh</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Diagnostic procedures for IgG4-related sclerosing cholangitis</article-title>
          <source>J Hepatobiliary Pancreat Sci</source>
          <year>2010</year>
          <month>9</month>
          <day>02</day>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamano</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Horiuchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unno</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Furuya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Akamatsu</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High serum IgG4 concentrations in patients with sclerosing pancreatitis</article-title>
          <source>N Engl J Med</source>
          <year>2001</year>
          <volume>344</volume>
          <fpage>732</fpage>
          <lpage>738</lpage>
          <pub-id pub-id-type="pmid">11236777</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bj&#xF6;rnsson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chari</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Smyrk</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Lindor</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature</article-title>
          <source>Hepatology</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>1547</fpage>
          <lpage>1554</lpage>
          <pub-id pub-id-type="pmid">17538931</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fujii</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Masuda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakanuma</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease</article-title>
          <source>Mod Pathol</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>884</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="pmid">17571078</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deshpande</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sainani</surname>
              <given-names>NI</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Pratt</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Mentha</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rubbia-Brandt</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material</article-title>
          <source>Mod Pathol</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>1287</fpage>
          <lpage>1295</lpage>
          <pub-id pub-id-type="pmid">19633647</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oyama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hashimoto</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Toki</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kobayashi</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis</article-title>
          <source>J Gastroenterol</source>
          <year>2007</year>
          <volume>42</volume>
          <fpage>550</fpage>
          <lpage>559</lpage>
          <pub-id pub-id-type="pmid">17653651</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Histologic features of the biopsied liver. (A, B) Lymphoplasmacytic and eosinophilic infiltration in the portal tracts (A: H&amp;E, &#xD7;200; B: H&amp;E, &#xD7;100). The inflammatory cell infiltrates are centered predominantly around the portal veins (arrows), while the hepatic artery (white arrowhead) and bile duct epithelia (black arrowhead) are relatively intact without degenerative changes. The portal tracts are mildly fibrotic, without an 'onion-skin' appearance. Immunohistochemical stain for IgG4 reveals several scattered IgG4-positive plasma cells in the portal tracts (C: IgG4 immunostaining, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjhep-17-76-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Histologic features of the pancreas (A-C). Diffuse lymphoplasmacytic infiltration of the pancreatic lobules and periductal areas with marked septal fibrosis is seen (A: H&amp;E, &#xD7;40). The inflammatory cells infiltrate the periductal areas without destruction of the ductal epithelia (B: H&amp;E, &#xD7;100). Obliterative phlebitis is frequently seen (arrow), while ductal epithelia and arteries are spared. (C: Elastic van Gieson, &#xD7;200). Abundant IgG4-positive plasma cells are seen in the pancreatic parenchyma (D: IgG4 immunostaining, &#xD7;400).</p>
      </caption>
      <graphic xlink:href="kjhep-17-76-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
